Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Bookmark and Share
Published: 25 Apr 2018
Views: 4354
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA

Dr Gandhi presents results at AACR 2018 from a trial assessing the response rate, overall survival and progression free survival of non-squamous non-small cell lung cancer patients treated with a combination of pembrolizumab and chemotherapy.

For more on these results, watch her interview with ecancer.